https://www.nasdaq.com/press-release/agile-therapeutics-to-present-at-the-40th-annual-j.p.-morgan-healthcare-conference
https://www.nasdaq.com/press-release/agile-therapeutics-to-present-at-the-biotech-showcase-and-h.c.-wainwright-bioconnect
https://www.nasdaq.com/press-release/agile-therapeutics-reports-third-quarter-2021-financial-results-2021-11-02
https://www.nasdaq.com/press-release/agile-therapeutics-to-report-third-quarter-2021-financial-results-and-provide
https://www.nasdaq.com/press-release/agile-therapeutics-applauds-congressional-chairs-letter-to-biden-administration
https://www.nasdaq.com/press-release/agile-therapeutics-appoints-josephine-torrente-to-its-board-of-directors-2021-10-08
https://www.nasdaq.com/press-release/agile-therapeutics-announces-pricing-of-%2422666650-underwritten-public-offering-of
https://www.nasdaq.com/press-release/agile-therapeutics-announces-proposed-underwritten-public-offering-of-common-stock-1
https://www.nasdaq.com/press-release/agile-therapeutics-announces-addition-of-twirlar-to-a-preferred-drug-position-on-medi
https://www.nasdaq.com/press-release/agile-therapeutics-partners-with-carli-lloyd-u.s.-womens-soccer-star-and-four-time-0
https://www.nasdaq.com/press-release/agile-therapeutics-partners-with-carli-lloyd-u.s.-womens-soccer-star-and-four-time
https://www.nasdaq.com/press-release/agile-therapeutics-to-participate-in-upcoming-investor-conferences-2021-09-07
https://www.nasdaq.com/press-release/agile-therapeutics-partners-with-telehealth-service-pandia-health-to-increase-womens
https://www.nasdaq.com/press-release/agile-therapeutics-reports-second-quarter-2021-financial-results-2021-07-26
https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-0
https://www.nasdaq.com/press-release/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide
https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july
https://www.nasdaq.com/press-release/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock
https://www.nasdaq.com/press-release/agile-therapeutics-to-participate-in-virtual-fireside-chat-as-part-of-the-2021-rbc
https://www.nasdaq.com/press-release/agile-therapeutics-reports-first-quarter-2021-financial-results-2021-05-04
https://www.nasdaq.com/press-release/agile-therapeutics-announces-presentation-of-safety-and-efficacy-data-of-twirlar
https://www.nasdaq.com/press-release/correcting-and-replacing-agile-therapeutics-2021-04-20
https://www.nasdaq.com/press-release/agile-therapeutics-to-report-first-quarter-2021-financial-results-and-provide
https://www.nasdaq.com/press-release/agile-therapeutics-to-present-at-upcoming-march-investor-conferences-2021-03-05
https://www.nasdaq.com/press-release/agile-therapeutics-reports-fourth-quarter-full-year-2020-financial-results-expands
https://www.nasdaq.com/press-release/agile-therapeutics-to-host-fourth-quarter-and-full-year-2020-financial-results
https://www.nasdaq.com/press-release/agile-therapeutics-to-participate-in-fireside-chat-at-the-h.c.-wainwright-bioconnect
https://www.nasdaq.com/press-release/agile-therapeutics-to-present-at-the-39th-annual-j.p.-morgan-healthcare-conference
https://www.nasdaq.com/press-release/agile-therapeutics-announces-nationwide-commercial-launch-and-availability-of-twirlar
https://www.nasdaq.com/press-release/agile-therapeutics-announces-peer-reviewed-publication-of-phase-3-secure-study
https://www.nasdaq.com/press-release/agile-therapeutics-to-participate-in-the-32nd-annual-piper-sandler-healthcare
https://www.nasdaq.com/press-release/agile-therapeutics-reports-third-quarter-2020-financial-results-2020-11-12
https://www.nasdaq.com/press-release/agile-therapeutics-to-host-third-quarter-2020-financial-results-conference-call-and
https://www.nasdaq.com/press-release/agile-therapeutics-to-present-at-the-oppenheimer-fall-healthcare-life-sciences
https://www.nasdaq.com/press-release/agile-therapeutics-to-participate-in-fireside-chat-at-the-h.c.-wainwright-22nd-annual
https://www.nasdaq.com/press-release/agile-therapeutics-announces-virtual-investor-analyst-day-on-monday-september-21-2020
https://www.nasdaq.com/press-release/agile-therapeutics-launches-im-so-done-campaign-to-inspire-women-to-take-an-active
https://www.nasdaq.com/press-release/agile-therapeutics-strengthens-executive-leadership-team-with-the-appointment-of-paul
https://www.nasdaq.com/press-release/agile-therapeutics-to-participate-in-maxim-groups-leading-innovators-in-womens-health
https://www.nasdaq.com/press-release/agile-therapeutics-reports-second-quarter-2020-financial-results-2020-08-11
https://www.nasdaq.com/press-release/agile-therapeutics-to-host-second-quarter-2020-financial-results-and-business-update
https://www.nasdaq.com/press-release/agile-therapeutics-to-join-russell-3000r-and-2000r-indexes-2020-06-16
https://www.nasdaq.com/press-release/agile-therapeutics-to-participate-in-virtual-fireside-chat-as-part-of-the-2020-rbc
https://www.nasdaq.com/press-release/agile-therapeutics-reports-first-quarter-2020-financial-results-2020-05-05
https://www.nasdaq.com/press-release/agile-therapeutics-to-host-first-quarter-2020-financial-results-and-business-update
https://www.nasdaq.com/press-release/agile-therapeutics-announces-changes-to-its-board-of-directors-2020-04-22
https://www.nasdaq.com/press-release/agile-therapeutics-inc.-nasdaq%3a-agrx-to-ring-nasdaq-stock-market-closing-bell-on
https://www.nasdaq.com/press-release/agile-therapeutics-announces-pricing-of-%2445-million-underwritten-public-offering-of
https://www.nasdaq.com/press-release/agile-therapeutics-announces-proposed-underwritten-public-offering-of-common-stock-0
https://www.nasdaq.com/press-release/agile-therapeutics-reports-fourth-quarter-and-full-year-2019-financial-results-2020
https://www.nasdaq.com/press-release/fda-approves-agile-therapeutics-inc.s-twirlar-levonorgestrel-and-ethinyl-estradiol
https://www.nasdaq.com/press-release/agile-therapeutics-inc.-enters-into-up-to-%2435-million-loan-facility-with-perceptive
https://www.nasdaq.com/press-release/agile-therapeutics-to-present-at-the-38th-annual-j.p.-morgan-healthcare-conference-in
https://www.nasdaq.com/press-release/agile-therapeutics-strengthens-commercial-leadership-team-2020-01-02
https://www.nasdaq.com/press-release/agile-therapeutics-to-present-at-biotech-showcasetm-2020-in-san-francisco-2019-12-19
https://www.nasdaq.com/press-release/agile-therapeutics-announces-fda-extension-of-twirlar-nda-review-period-2019-11-14
https://www.nasdaq.com/press-release/thinking-about-buying-stock-in-abbvie-agile-therapeutics-intel-peloton-interactive-or
https://www.nasdaq.com/press-release/agile-therapeutics-announces-favorable-outcome-of-fda-advisory-committee-meeting-for
https://www.nasdaq.com/press-release/agile-therapeutics-reports-third-quarter-2019-financial-results-2019-10-28
https://www.nasdaq.com/press-release/agile-therapeutics-reports-fourth-quarter-and-full-year-2018-financial-results-2019
